Residency Listing

Dana-Farber Cancer Institute
Department of Pharmacy
450 Brookline Avenue
Boston, MA 02215
Code: 13012
NMS Code: 660260
Postgraduate Year Two (PGY2)
Oncology Pharmacy
Accreditation Status: Accredited
Residency Program Director: Hillary Prescott, Pharm.D., BCOP
Director of Pharmacy: Sylvia Bartel, RPh, MHP
(617) 632-2110
Fax: (617) 632-2254
Residency Information:
Duration/Type: 12 mo residency
Number of Positions: 2
Interview Required: Yes
Residency Special Features:   This program is designed to provide the resident opportunities to develop clinical competence in oncology pharmacy practice. The resident will gain experience in the following areas of practice: adult ambulatory oncology, inpatient medical and hematologic oncology, inpatient stem cell transplant, palliative care, pediatric oncology, medication safety, investigational drug service and academia. Other educational experiences include weekly topic discussions, grand rounds, tumor boards and other oncology related lectures.
Fringe Benefits:   The resident receives health insurance, sick leave, paid vacation, and professional travel reimbursements
Special Requirements for Acceptance:   Pharm.D and PGY-1 Pharmacy residency required with experience in oncology preferred, and eligibility for licensure in Massachusetts
Training Site Type: Hospital/Cancer Center
Owner Affiliate: Private
Model Type(s): Teaching Hospital
Tax Status: Nonprofit
Number of Medical Centers: 4
Total Beds: 110
Average Daily Census: 110
Site Special Features:   Adult patient care is delivered through Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), which provides outpatient care at Dana-Farber and inpatient services at Brigham and Women’s Hospital. Similarly, pediatric patients are seen at Dana-Farber’s Jimmy Fund Clinic for their outpatient care while pediatric patients requiring hospitalization are treated at Children’s Hospital Boston.